Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Boehringer Ingelheim announces FDA acceptance of BLA for spesolimab

Pharmaceutical-Business-ReviewDecember 21, 2021

Tag: Boehringer Ingelheim , spesolimab , GPP

PharmaSources Customer Service